HK1175197A1 - 肽和包含 肽的疫苗 - Google Patents

肽和包含 肽的疫苗

Info

Publication number
HK1175197A1
HK1175197A1 HK13102321.1A HK13102321A HK1175197A1 HK 1175197 A1 HK1175197 A1 HK 1175197A1 HK 13102321 A HK13102321 A HK 13102321A HK 1175197 A1 HK1175197 A1 HK 1175197A1
Authority
HK
Hong Kong
Prior art keywords
tem8
vaccines
peptides
same
tem8 peptides
Prior art date
Application number
HK13102321.1A
Other languages
English (en)
Inventor
Takuya Tsunoda
Ryuji Osawa
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of HK1175197A1 publication Critical patent/HK1175197A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK13102321.1A 2007-04-11 2010-06-02 肽和包含 肽的疫苗 HK1175197A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91119407P 2007-04-11 2007-04-11

Publications (1)

Publication Number Publication Date
HK1175197A1 true HK1175197A1 (zh) 2013-06-28

Family

ID=39863572

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13102321.1A HK1175197A1 (zh) 2007-04-11 2010-06-02 肽和包含 肽的疫苗

Country Status (13)

Country Link
US (1) US8367799B2 (zh)
EP (2) EP2155872A4 (zh)
JP (1) JP5320544B2 (zh)
KR (1) KR20100016355A (zh)
CN (2) CN101711280B (zh)
BR (1) BRPI0811021A2 (zh)
CA (1) CA2683454A1 (zh)
HK (1) HK1175197A1 (zh)
IL (2) IL201386A0 (zh)
MX (1) MX2009010965A (zh)
RU (2) RU2498993C2 (zh)
TW (2) TWI434853B (zh)
WO (1) WO2008126413A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI500932B (zh) * 2008-12-05 2015-09-21 Oncotherapy Science Inc Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
US8574902B2 (en) 2009-03-05 2013-11-05 Macrocure Ltd. Activated leukocyte composition and uses for wound healing
TW201136604A (en) 2009-12-14 2011-11-01 Oncotherapy Science Inc TMEM22 peptides and vaccines including the same
SG10201501857YA (en) * 2010-03-11 2015-05-28 Oncotherapy Science Inc Hjurp Peptides And Vaccines Including The Same
RU2012147590A (ru) * 2010-04-09 2014-05-20 Онкотерапи Сайенс, Инк. Пептиды cdca5 и содержащие их вакцины
US8557777B2 (en) * 2010-07-09 2013-10-15 The Board Of Trustees Of The University Of Illinois Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides
EA201390314A1 (ru) 2010-09-09 2013-11-29 Макрокьюэ, Лтд. Супернатант, кондиционированный активированными лейкоцитами, и его использование для заживления ран
SG190407A1 (en) 2010-12-02 2013-06-28 Oncotherapy Science Inc Tomm34 peptides and vaccines including the same
BR112014001363B1 (pt) * 2011-08-12 2021-06-01 Oncotherapy Science, Inc. Composições para indução de um linfócito t citotóxico (ctl), para indução de uma célula apresentadora de antígeno (apc) tendo capacidade de indução de ctl, composição farmacêutica, métodos in vitro para indução de apc e de ctl, usos de peptídeos e vetor
DK2771350T3 (en) * 2011-10-28 2018-04-30 Onco Therapy Science Inc TOP PEPTIDES AND VACCINES INCLUDING THESE
RU2015126849A (ru) * 2012-12-04 2017-01-12 Онкотерапи Сайенс, Инк. Пептиды sema5в и вакцины, содержащие эти пептиды
TW201636358A (zh) * 2014-12-09 2016-10-16 腫瘤療法 科學股份有限公司 對於ｔｈ１細胞之ｇｐｃ３抗原決定位胜肽及含此之疫苗
CN106084026B (zh) * 2016-06-19 2019-10-25 中国人民解放军军事医学科学院生物工程研究所 肿瘤血管内皮细胞标志物8突变体、其融合蛋白及应用
RU2706554C1 (ru) * 2018-12-13 2019-11-19 Российская Федерация, от имени которой выступает ФОНД ПЕРСПЕКТИВНЫХ ИССЛЕДОВАНИЙ Способ создания противоинфекционной иммунологической защиты к Salmonella typhimurium и Listeria monocytogenes с помощью трансгенеза Т-лимфоцитов

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
EP0841945B1 (en) 1995-08-03 2006-03-08 Rijksuniversiteit te Leiden Cell derived antigen presenting vesicles
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
JP2000516090A (ja) 1996-07-26 2000-12-05 スローン―ケッタリング インスティチュート フォー キャンサー リサーチ 遺伝子的免疫化のための方法と試薬
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US6426205B1 (en) * 1997-10-24 2002-07-30 Mount Sinai Hospital Corporation Methods and compositions for modulating ubiquitin dependent proteolysis
US7041297B1 (en) 1998-06-25 2006-05-09 Sumitomo Pharmaceuticals Company Tumor antigen peptides originating in cyclophilin B
US6465717B1 (en) * 1998-11-20 2002-10-15 E. I. Du Pont De Nemours And Company Sterol metabolism enzymes
EP1710299A3 (en) 1998-12-30 2007-01-10 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
US7402660B2 (en) * 2000-08-02 2008-07-22 The Johns Hopkins University Endothelial cell expression patterns
EP1395657B1 (en) * 2000-12-05 2007-04-18 Wisconsin Alumni Research Foundation Receptor for bacillus anthracis toxin
US20030092616A1 (en) * 2001-05-25 2003-05-15 Akio Matsuda STAT6 activation gene
US6936707B2 (en) * 2001-07-11 2005-08-30 Zeon Corporation Modified DNA molecule, recombinant containing the same, and uses thereof
BRPI0308740B1 (pt) * 2002-03-19 2018-11-21 Monsanto Technology Llc molécula de ácido nucléico codificando uma homogentisato prenil transferase (“hpt”) e método de produzir planta tendo semente com nível de tocoferol aumentado
US7160994B2 (en) * 2002-03-28 2007-01-09 Trustees Of The University Of Pennsylvania Osteoclast-specific genes and proteins and uses thereof
EP2267021B1 (en) * 2002-09-12 2015-02-18 Oncotherapy Science, Inc. KDR peptides and vaccines comprising the same
US20080171058A1 (en) * 2003-11-13 2008-07-17 Polly Gregor Compositions and Methods For Synergistic Induction of Antitumor Immunity
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Ｃｘａｄｒｌ１またはｇｃｕｄ１タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
US7915036B2 (en) 2004-09-13 2011-03-29 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compositions comprising T cell receptors and methods of use thereof
CN101287831B (zh) 2005-09-13 2013-05-15 国立大学法人三重大学 T细胞受体和编码该受体的核酸
ITRM20060337A1 (it) 2006-06-27 2007-12-28 Biosoot Srl Gene tem8 (tumor endotelial marker 8) e sue forme di espressione ed usi diagnostici e terapeutici

Also Published As

Publication number Publication date
KR20100016355A (ko) 2010-02-12
RU2009141595A (ru) 2011-05-20
CN101711280B (zh) 2013-04-10
US8367799B2 (en) 2013-02-05
RU2013131089A (ru) 2015-01-10
IL220752A0 (en) 2012-08-30
EP2155872A4 (en) 2010-04-28
AU2008238739A1 (en) 2008-10-23
US20120093843A1 (en) 2012-04-19
CN101711280A (zh) 2010-05-19
CN102786582B (zh) 2014-06-11
EP2508601B1 (en) 2014-11-05
IL201386A0 (en) 2011-08-01
JP5320544B2 (ja) 2013-10-23
CA2683454A1 (en) 2008-10-23
TWI434853B (zh) 2014-04-21
EP2155872A1 (en) 2010-02-24
JP2010523471A (ja) 2010-07-15
MX2009010965A (es) 2009-12-01
WO2008126413A1 (en) 2008-10-23
TW201425333A (zh) 2014-07-01
TW200906850A (en) 2009-02-16
EP2508601A3 (en) 2013-02-13
BRPI0811021A2 (pt) 2014-10-21
EP2508601A2 (en) 2012-10-10
RU2498993C2 (ru) 2013-11-20
CN102786582A (zh) 2012-11-21

Similar Documents

Publication Publication Date Title
IL220752A0 (en) Tem8 peptides and vaccines comprising the same
EP2326718A4 (en) INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THEM
HK1145506A1 (en) Peptides and their use
EP2226088A4 (en) FLAT SEAL FOR A SYRINGE AND SYRINGE WITH THE FLAT SEAL
IL209967A0 (en) Cdca1 epitope peptides and vaccines containing the same
HRP20150195T1 (en) Peptides and their use
IL209869A0 (en) Iqgap3 epitope peptides and vaccines containing the same
IL209870A0 (en) Mybl2 epitope peptides and vaccines containing the same
HK1157204A1 (zh) 表位肽及包含它們的疫苗
IL229926A (en) 3neil peptides and vaccines containing them
GB0702022D0 (en) Peptides and their use
IL216211A0 (en) Cdc45l peptides and vaccines including the same
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
ZA201104890B (en) Wdrpuh epitope peptides and vaccines containing the same
IL219927A0 (en) Mybl2 peptides and vaccines containing the same
GB0710813D0 (en) Peptides and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180410